Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-03-27
2007-03-27
Epps-Ford, Janet L. (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S002600, C424S093210, C424S093100, C435S069100, C435S173300, C435S325000
Reexamination Certificate
active
11179322
ABSTRACT:
The present invention provides prophylactic and therapeutic methods of treating the ductal epithelium of an exocrine gland, in particular a mammary gland, for disease, in particular cancer. The methods comprise contacting the ductal epithelium of the exocrine gland with an epithelium-destroying gent, preferably by ductal cannulation, so as to realize a prophylactic or therapeutic effect.
REFERENCES:
patent: 4568673 (1986-02-01), Brooks
patent: 4623660 (1986-11-01), Richardson
patent: 5149527 (1992-09-01), Weisenthal
patent: 5215904 (1993-06-01), Gould et al.
patent: 5236844 (1993-08-01), Basset et al.
patent: 5304489 (1994-04-01), Rosen
patent: 5383849 (1995-01-01), Johlin et al.
patent: 5437863 (1995-08-01), Williams et al.
patent: 5472441 (1995-12-01), Edwards et al.
patent: 5478556 (1995-12-01), Elliott et al.
patent: 5585096 (1996-12-01), Martuza et al.
patent: 5651964 (1997-07-01), Hung et al.
patent: 5662896 (1997-09-01), Barber et al.
patent: 5668122 (1997-09-01), Fife et al.
patent: 5677292 (1997-10-01), Li et al.
patent: 5744133 (1998-04-01), Lathe et al.
patent: 5747469 (1998-05-01), Roth et al.
patent: 5780009 (1998-07-01), Karatzas
patent: 5833975 (1998-11-01), Paoletti et al.
patent: 5837693 (1998-11-01), German et al.
patent: 5858365 (1999-01-01), Faller et al.
patent: 5866550 (1999-02-01), Frisch
patent: 6096874 (2000-08-01), Wallace et al.
patent: 0 118365 (1984-09-01), None
patent: 0 352722 (1990-01-01), None
patent: 0 657174 (1995-06-01), None
patent: WO 81/02839 (1981-10-01), None
patent: WO 93/02556 (1993-02-01), None
patent: WO 94/09160 (1994-04-01), None
patent: WO 94/26915 (1994-11-01), None
Ariyama et al.Medline, AN: 91185944, International J. Pancreat, 7, 1-3, 37-47, abstract (1990).
Berchem et al.,Cancer Research, 55:735-738 (Feb. 15, 1995).
Berkow et al.;The Merck Manual of Diagnosis and Therapy, p. 1818, 16thed., Merck Research Laboratories (1992).
Bièche et al.,Cancer Research, 54:4274-4276 (Aug. 15, 1994).
Chen et al.,Proc. Natl. Acad. Sci. USA, 91:3054-3057 (Apr. 1994).
Culver et al. “Gene Therapy for Cancer,”TIG, 10(5): 174-178 ( May 1994).
Dorland's Illustrated Medical Dictionary, p. 425 (1994).
Field et al;Field's Virology, pp. 221-223, Lippincott-Raven (1996).
Fraenkel-Conrat et al.;Virology, p. 283, Prentice-Hall (1982).
Friedman. “Gene Therapy of Cancer through Restoration of Tumor-Suppressor Functions?”Cancer(supp) 70(6): 1810-1816 (1992).
Frykberg et al., “Overview of the Biology and Management of Ductal Carcinoma in Situ of the Breast,” DatabaseMedline, File Server Stn Karlsruhe, Abstract 94273121 (1994).
Fujiwara et al. “Gene Therapeutics and Gene Therapy for Cancer,”Current Opinion in Oncology, 6(1):96-105 (Jan. 1994).
Hanby et al.,Proc. Annu. Meet. Am. Assoc. Cancer Res., 35:A1085 (1994).
Haran et al.,Cancer Research, 54:5511-5514 (Nov. 1, 1994).
Hodgson. “Advances in Vector Systems for Gene Therapy,”Exp Opin Ther. Patents, 5(5): 459-468 (1995).
Kohn et al.;FASEB II: 635-639 (Jul. 1997).
LaFont et al. “Which Gene for Which Restenosis?”The Lancet, 346: 1442-1443 (Dec. 2, 1995).
Love, Susan M. et al:Dr. Susan Love's Breast Book, p. 219, 2ndedition, Reading, Mass: Perseus Books (1995).
Lukac et al. Cancerlit Database, AN: 94696782 Non-Serial (1993) CCPC-93: 2ndInternational Cancer Chemo. Prevention Conference, Apr. 28-30, 1993, Germany.
Manome et al.,Cancer Research, 54:5408-5413 (Oct. 15, 1994).
Marshall, E.; “Gene Therapy's Growing Pains,”Science, 269: 1050-1055 (Apr. 25, 1995).
Mastrangelo et al.Seminars in Oncology, 23(1): 4-21 (Feb. 1996).
Miller et al. “Targeted Vectors for Gene Therapy,”FASEB, vol. 9: 190-199 (1995).
Miyadera et al.,Cancer Research, 55:1687-1690 (Apr. 15, 1995).
Orkin et al. “Report and Recommendations . . . Gene Therapy,”NIHPress: 1-40 (1995).
Osaki et al.,Cancer Research, 54:5258-5261 (Oct. 15, 1994).
Pansera,Medical Hypotheses, 33(2):107-111 (Oct. 1990).
Pitts,Molecular Carcinogenesis, 11(3):127-130 (Nov. 1994).
Russo et al., “Biology of Disease. Comparative Study of Human and Rat Mammary Tumorigenesis,”Laboratory Investigation, 62(3):244-278 (Mar. 1990).
Stedman's Medical Dictionary, p. 438, column 2, (1995).
Tamaki et al., “A Human Monoclonal Antibody Derived from Axillary Lymph Nodes of a Breast Cancer Patient,”Hybridoma, 8(3):293-302 (Jun. 1989).
Tamm et al., “Interleukin 6 Decreases Cell—Cell Association and Increases Motility of Ductal Breast Carcinoma Cells,”The Journal of Experimental Medicine, 170:1649-1669 (Nov. 1989).
Tannock et al.The Basic Science of Oncology, pp. 225-227, 2ndEd., McGraw Hill (1992).
Webster's II New Riverside University Dictionary, p. 944, The Riverside Publishing Company, (1994).
Zenklusen et al., “The Immunohistochemical Reactivity of a New Anti-Epithelial Monoclonal Antibody (MAb b-12) Against Breast Carcinoma and Other Normal and Neoplastic Human Tissues,”Virchows Archiv A Pathological Anatomy and Histopathology, 413:3-10 (1988).
Cancerlit, 91670291, 1990, Abstract.
Cho et. al.; Macromolecular versus small-molecular therapeutics: drug discovery, development and clinical considerations, 1996, TIBECH, vol. 14.
Embase, 94182984, 1994, Abstract.
Embase; 1994310625, 2002 Abstract.
Henderson et. al.; Hormonal Chemoprevention of Cancer in Women, 1993, Science, vol. 259: 633-638.
Jaiyesimi et. al.; Use of Tamoxifen for Breast Cancer: Twenty-Eight Years Later, 1995, Journal of Clinical Oncology, vol. 13: 513-529.
Jordan; Tamoxifen for Breast Cancer Prevention, 1995, Tamoxifen for Prevention: 144-149.
Mastrangelo et. al.; Gene Therapy for Human Cancer: An Essay for Clinicians, 1996, Seminars in Oncology, vol. 23: 4-21.
Medline, 92200449, 1992, Abstract.
Medline, 94058289, 1993, Abstract.
Meng et. al.; Tumor Suppressor Genes as Targets for Cancer Gene Therapy, 1999, Gene Therapy of Cancer: 3-18.
Stewart; The role of chemotherapy in the treatment of gliomas in adults, 1989, Cancer Treatment Reviews 16: 129-160.
Barnes & Thornburg LLP
Epps-Ford Janet L.
Johns Hopkins University School Of Medicine
Leavitt Maria
LandOfFree
Prophylactic and therapeutic treatment of the ductal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylactic and therapeutic treatment of the ductal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic and therapeutic treatment of the ductal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3750310